cached image

Michael J. Schell - Publications

Affiliations: 
Uniformed Services University of the Health Sciences, Bethesda, MD 
Area:
Dendritic spine actin
Website:
http://www.usuhs.mil/nes/schell.htm

45/299 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Gupta A, Schell MJ, Bhattacharjee A, Lutsenko S, Hubbard AL. Myosin Vb mediates copper export in polarized hepatocytes. Journal of Cell Science. PMID 26823605 DOI: 10.1242/Jcs.175307  0.92
2015 Ngalula KP, Cramer N, Schell MJ, Juliano SL. Transplanted Neural Progenitor Cells from Distinct Sources Migrate Differentially in an Organotypic Model of Brain Injury. Frontiers in Neurology. 6: 212. PMID 26500604 DOI: 10.3389/fneur.2015.00212  0.92
2015 Nyasae LK, Schell MJ, Hubbard AL. Corrigendum to Copper Directs ATP7B to the Apical Domain of Hepatic Cells via Basolateral Endosomes [Traffic (2014) 1344-1365] Traffic. 16: 99-99. DOI: 10.1111/Tra.12250  0.92
2014 Nyasae LK, Schell MJ, Hubbard AL. Copper directs ATP7B to the apical domain of hepatic cells via basolateral endosomes. Traffic (Copenhagen, Denmark). 15: 1344-65. PMID 25243755 DOI: 10.1111/Tra.12229  0.92
2012 Zhang W, Tingare A, Ng DC, Johnson HW, Schell MJ, Lord RL, Chawla S. IP3-dependent intracellular Ca2+ release is required for cAMP-induced c-fos expression in hippocampal neurons. Biochemical and Biophysical Research Communications. 425: 450-5. PMID 22846568 DOI: 10.1016/J.Bbrc.2012.07.122  0.92
2011 Yang L, Kotomura N, Ho YK, Zhi H, Bixler S, Schell MJ, Giam CZ. Complex cell cycle abnormalities caused by human T-lymphotropic virus type 1 Tax. Journal of Virology. 85: 3001-9. PMID 21209109 DOI: 10.1128/JVI.00086-10  0.92
2010 Letcher AJ, Schell MJ, Irvine RF. A femtomole-sensitivity mass assay for inositol hexakisphosphate. Methods in Molecular Biology (Clifton, N.J.). 645: 61-71. PMID 20645181 DOI: 10.1007/978-1-60327-175-2_4  0.92
2010 Halim ND, Mcfate T, Mohyeldin A, Okagaki P, Korotchkina LG, Patel MS, Jeoung NH, Harris RA, Schell MJ, Verma A. Phosphorylation status of pyruvate dehydrogenase distinguishes metabolic phenotypes of cultured rat brain astrocytes and neurons. Glia. 58: 1168-76. PMID 20544852 DOI: 10.1002/Glia.20996  0.92
2010 Schell MJ. Inositol trisphosphate 3-kinases: focus on immune and neuronal signaling. Cellular and Molecular Life Sciences : Cmls. 67: 1755-78. PMID 20066467 DOI: 10.1007/s00018-009-0238-5  0.92
2009 Johnson HW, Schell MJ. Neuronal IP3 3-kinase is an F-actin-bundling protein: role in dendritic targeting and regulation of spine morphology. Molecular Biology of the Cell. 20: 5166-80. PMID 19846664 DOI: 10.1091/mbc.E09-01-0083  0.92
2008 Letcher AJ, Schell MJ, Irvine RF. Do mammals make all their own inositol hexakisphosphate? The Biochemical Journal. 416: 263-70. PMID 18684107 DOI: 10.1042/BJ20081417  0.92
2008 McFate T, Mohyeldin A, Lu H, Thakar J, Henriques J, Halim ND, Wu H, Schell MJ, Tsang TM, Teahan O, Zhou S, Califano JA, Jeoung NH, Harris RA, Verma A. Pyruvate dehydrogenase complex activity controls metabolic and malignant phenotype in cancer cells. The Journal of Biological Chemistry. 283: 22700-8. PMID 18541534 DOI: 10.1074/jbc.M801765200  0.92
2007 Lloyd-Burton SM, Yu JC, Irvine RF, Schell MJ. Regulation of inositol 1,4,5-trisphosphate 3-kinases by calcium and localization in cells. The Journal of Biological Chemistry. 282: 9526-35. PMID 17284449 DOI: 10.1074/jbc.M610253200  0.92
2007 Schell MJ. Immunohistochemistry for D-serine in brain D-Amino Acids: a New Frontier in Amino Acid and Protein Research - Practical Methods and Protocols. 173-179.  0.92
2006 Schell MJ, Irvine RF. Calcium-triggered exit of F-actin and IP(3) 3-kinase A from dendritic spines is rapid and reversible. The European Journal of Neuroscience. 24: 2491-503. PMID 17100838 DOI: 10.1111/j.1460-9568.2006.05125.x  0.92
2006 Irvine RF, Lloyd-Burton SM, Yu JC, Letcher AJ, Schell MJ. The regulation and function of inositol 1,4,5-trisphosphate 3-kinases. Advances in Enzyme Regulation. 46: 314-23. PMID 16857241 DOI: 10.1016/j.advenzreg.2006.01.009  0.92
2006 Chalmers M, Schell MJ, Thorn P. Agonist-evoked inositol trisphosphate receptor (IP3R) clustering is not dependent on changes in the structure of the endoplasmic reticulum. The Biochemical Journal. 394: 57-66. PMID 16274363 DOI: 10.1042/BJ20051130  0.92
2005 Yu JC, Lloyd-Burton SM, Irvine RF, Schell MJ. Regulation of the localization and activity of inositol 1,4,5-trisphosphate 3-kinase B in intact cells by proteolysis. The Biochemical Journal. 392: 435-41. PMID 16173920 DOI: 10.1042/BJ20050829  0.92
2005 Young KW, Billups D, Nelson CP, Johnston N, Willets JM, Schell MJ, Challiss RA, Nahorski SR. Muscarinic acetylcholine receptor activation enhances hippocampal neuron excitability and potentiates synaptically evoked Ca(2+) signals via phosphatidylinositol 4,5-bisphosphate depletion. Molecular and Cellular Neurosciences. 30: 48-57. PMID 15996483 DOI: 10.1016/j.mcn.2005.05.006  0.92
2005 Brough D, Schell MJ, Irvine RF. Agonist-induced regulation of mitochondrial and endoplasmic reticulum motility. The Biochemical Journal. 392: 291-7. PMID 15982187 DOI: 10.1042/BJ20050738  0.92
2004 González B, Schell MJ, Letcher AJ, Veprintsev DB, Irvine RF, Williams RL. Structure of a human inositol 1,4,5-trisphosphate 3-kinase: substrate binding reveals why it is not a phosphoinositide 3-kinase. Molecular Cell. 15: 689-701. PMID 15350214 DOI: 10.1016/J.Molcel.2004.08.004  0.92
2004 Schell MJ. The N-methyl D-aspartate receptor glycine site and D-serine metabolism: an evolutionary perspective. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 359: 943-64. PMID 15306409 DOI: 10.1098/rstb.2003.1399  0.92
2004 Kyttälä A, Ihrke G, Vesa J, Schell MJ, Luzio JP. Two motifs target Batten disease protein CLN3 to lysosomes in transfected nonneuronal and neuronal cells. Molecular Biology of the Cell. 15: 1313-23. PMID 14699076 DOI: 10.1091/mbc.E03-02-0120  0.92
2002 Nash MS, Schell MJ, Atkinson PJ, Johnston NR, Nahorski SR, Challiss RA. Determinants of metabotropic glutamate receptor-5-mediated Ca2+ and inositol 1,4,5-trisphosphate oscillation frequency. Receptor density versus agonist concentration. The Journal of Biological Chemistry. 277: 35947-60. PMID 12119301 DOI: 10.1074/jbc.M205622200  0.92
2002 Kidd JF, Pilkington MF, Schell MJ, Fogarty KE, Skepper JN, Taylor CW, Thorn P. Paclitaxel affects cytosolic calcium signals by opening the mitochondrial permeability transition pore. The Journal of Biological Chemistry. 277: 6504-10. PMID 11724773 DOI: 10.1074/jbc.M106802200  0.92
2001 Schell MJ, Erneux C, Irvine RF. Inositol 1,4,5-trisphosphate 3-kinase A associates with F-actin and dendritic spines via its N terminus. The Journal of Biological Chemistry. 276: 37537-46. PMID 11468283 DOI: 10.1074/jbc.M104101200  0.92
2001 Irvine RF, Schell MJ. Back in the water: the return of the inositol phosphates. Nature Reviews. Molecular Cell Biology. 2: 327-38. PMID 11331907 DOI: 10.1038/35073015  0.92
1999 Schell MJ, Letcher AJ, Brearley CA, Biber J, Murer H, Irvine RF. PiUS (Pi uptake stimulator) is an inositol hexakisphosphate kinase. Febs Letters. 461: 169-72. PMID 10567691 DOI: 10.1016/S0014-5793(99)01462-3  0.92
1999 Irvine RF, McNulty TJ, Schell MJ. Inositol 1,3,4,5-tetrakisphosphate as a second messenger--a special role in neurones? Chemistry and Physics of Lipids. 98: 49-57. PMID 10358927 DOI: 10.1016/S0009-3084(99)00017-1  0.92
1999 Koizumi S, Bootman MD, Bobanovi? LK, Schell MJ, Berridge MJ, Lipp P. Characterization of elementary Ca2+ release signals in NGF-differentiated PC12 cells and hippocampal neurons. Neuron. 22: 125-37. PMID 10027295 DOI: 10.1016/S0896-6273(00)80684-4  0.92
1998 Cooper DM, Schell MJ, Thorn P, Irvine RF. Regulation of adenylyl cyclase by membrane potential. The Journal of Biological Chemistry. 273: 27703-7. PMID 9765307 DOI: 10.1074/jbc.273.42.27703  0.92
1997 Eliasson MJ, Blackshaw S, Schell MJ, Snyder SH. Neuronal nitric oxide synthase alternatively spliced forms: prominent functional localizations in the brain. Proceedings of the National Academy of Sciences of the United States of America. 94: 3396-401. PMID 9096405 DOI: 10.1073/pnas.94.7.3396  0.92
1997 Schell MJ, Cooper OB, Snyder SH. D-aspartate localizations imply neuronal and neuroendocrine roles. Proceedings of the National Academy of Sciences of the United States of America. 94: 2013-8. PMID 9050896 DOI: 10.1073/pnas.94.5.2013  0.92
1997 Schell MJ, Brady RO, Molliver ME, Snyder SH. D-serine as a neuromodulator: regional and developmental localizations in rat brain glia resemble NMDA receptors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 17: 1604-15. PMID 9030620  0.92
1995 Schell MJ, Molliver ME, Snyder SH. D-serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proceedings of the National Academy of Sciences of the United States of America. 92: 3948-52. PMID 7732010 DOI: 10.1073/PNAS.92.9.3948  0.92
1995 Sabatini DM, Pierchala BA, Barrow RK, Schell MJ, Snyder SH. The rapamycin and FKBP12 target (RAFT) displays phosphatidylinositol 4-kinase activity. The Journal of Biological Chemistry. 270: 20875-8. PMID 7673106 DOI: 10.1074/Jbc.270.36.20875  0.92
1994 Maurice M, Schell MJ, Lardeux B, Hubbard AL. Biosynthesis and intracellular transport of a bile canalicular plasma membrane protein: studies in vivo and in the perfused rat liver. Hepatology (Baltimore, Md.). 19: 648-55. PMID 8119690 DOI: 10.1002/Hep.1840190316  0.92
1994 Dinerman JL, Dawson TM, Schell MJ, Snowman A, Snyder SH. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proceedings of the National Academy of Sciences of the United States of America. 91: 4214-8. PMID 7514300 DOI: 10.1073/Pnas.91.10.4214  0.92
1993 Schell MJ, Danoff SK, Ross CA. Inositol (1,4,5)-trisphosphate receptor: characterization of neuron-specific alternative splicing in rat brain and peripheral tissues. Brain Research. Molecular Brain Research. 17: 212-6. PMID 8389956 DOI: 10.1016/0169-328X(93)90004-9  0.92
1993 Scott L, Schell MJ, Hubbard AL. Isolation of plasma membrane sheets and plasma membrane domains from rat liver. Methods in Molecular Biology (Clifton, N.J.). 19: 59-69. PMID 8220707 DOI: 10.1385/0-89603-236-1:59  0.92
1992 Schell MJ, Maurice M, Stieger B, Hubbard AL. 5'nucleotidase is sorted to the apical domain of hepatocytes via an indirect route. The Journal of Cell Biology. 119: 1173-82. PMID 1447295 DOI: 10.1083/Jcb.119.5.1173  0.92
1992 Ross CA, Danoff SK, Schell MJ, Snyder SH, Ullrich A. Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. Proceedings of the National Academy of Sciences of the United States of America. 89: 4265-9. PMID 1374893 DOI: 10.1073/Pnas.89.10.4265  0.92
1990 Margolis RN, Schell MJ, Taylor SI, Hubbard AL. Hepatocyte plasma membrane ECTO-ATPase (pp120/HA4) is a substrate for tyrosine kinase activity of the insulin receptor. Biochemical and Biophysical Research Communications. 166: 562-6. PMID 2137339 DOI: 10.1016/0006-291X(90)90845-E  0.92
1987 Parkinson JF, Akard LP, Schell MJ, Gabig TG. Cell-free activation of phagocyte NADPH-oxidase: tissue and differentiation-specific expression of cytosolic cofactor activity. Biochemical and Biophysical Research Communications. 145: 1198-204. PMID 3038092 DOI: 10.1016/0006-291X(87)91564-6  0.92
1987 Gabig TG, English D, Akard LP, Schell MJ. Regulation of neutrophil NADPH oxidase activation in a cell-free system by guanine nucleotides and fluoride. Evidence for participation of a pertussis and cholera toxin-insensitive G protein. The Journal of Biological Chemistry. 262: 1685-90. PMID 3027097  0.92
Low-probability matches
2019 Chen DT, Schell MJ, Fulp WJ, Pettersson F, Kim S, Gray JE, Haura EB. Application of Bayesian predictive probability for interim futility analysis in single-arm phase II trial. Translational Cancer Research. 8: S404-S420. PMID 31456910 DOI: 10.21037/Tcr.2019.05.17  0.28
1997 Schell MJ, Brady Jr. RO, Molliver ME, Snyder SH. d-Serine as a Neuromodulator: Regional and Developmental Localizations in Rat Brain Glia Resemble NMDA Receptors The Journal of Neuroscience. 17: 1604-1615. DOI: 10.1523/JNEUROSCI.17-05-01604.1997  0.12
2021 Kim DW, Tan E, Zhou JM, Schell MJ, Martinez M, Yu J, Carballido E, Mehta R, Strosberg J, Imanirad I, Kim RD. A phase 1/2 trial of ibrutinib in combination with pembrolizumab in patients with mismatch repair proficient metastatic colorectal cancer. British Journal of Cancer. PMID 33828254 DOI: 10.1038/s41416-021-01368-z  0.01
2021 Chung CH, Bonomi M, Steuer CE, Li J, Bhateja P, Johnson M, Masannat J, Song F, Hernandez-Prera JC, Wenig BM, Molina H, Farinhas JM, McMullen CP, Wadsworth JT, Patel KB, ... ... Schell MJ, et al. Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study. Cancers. 13. PMID 33803335 DOI: 10.3390/cancers13051180  0.04
2021 Kamal Y, Dwan D, Hoehn HJ, Sanz-Pamplona R, Alonso MH, Moreno V, Cheng C, Schell MJ, Kim Y, Felder SI, Rennert HS, Melas M, Lazaris C, Bonner JD, Siegel EM, et al. Tumor immune infiltration estimated from gene expression profiles predicts colorectal cancer relapse. Oncoimmunology. 10: 1862529. PMID 33763292 DOI: 10.1080/2162402X.2020.1862529  0.01
2020 Kim DW, Schell MJ, Kim RD. Need for More Comprehensive Evaluation of Immune-Related Adverse Events in Immunotherapy for Biliary Tract Cancer-Reply. Jama Oncology. PMID 33090188 DOI: 10.1001/jamaoncol.2020.4821  0.04
2020 Perez BA, Kim S, Wang M, Karimi AM, Powell C, Li J, Dilling TJ, Chiappori A, Latifi K, Rose T, Lannon A, MacMillan G, Saller J, Grass GD, Rosenberg S, ... ... Schell MJ, et al. A Prospective Single Arm Phase I/II Study: Ipilimumab and Nivolumab with Thoracic Radiotherapy after Platinum Chemotherapy in Extensive-Stage Small Cell Lung Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 33002543 DOI: 10.1016/j.ijrobp.2020.09.031  0.04
2020 Zhao Y, Amorrortu RP, Fenske NA, Cherpelis B, Messina JL, Sondak VK, Giuliano AR, Schell MJ, Waterboer T, Pawlita M, McKay-Chopin S, Gheit T, Tommasino M, Rollison DE. Cutaneous viral infections associated with ultraviolet radiation exposure. International Journal of Cancer. PMID 32818302 DOI: 10.1002/Ijc.33263  0.01
2020 Pointer DT, Roife D, Powers BD, Murimwa G, Elessawy S, Thompson ZJ, Schell MJ, Hodul PJ, Pimiento JM, Fleming JB, Malafa MP. Neutrophil to lymphocyte ratio, not platelet to lymphocyte or lymphocyte to monocyte ratio, is predictive of patient survival after resection of early-stage pancreatic ductal adenocarcinoma. Bmc Cancer. 20: 750. PMID 32782024 DOI: 10.1186/s12885-020-07182-9  0.01
2020 Yuan Z, Frazer M, Ahmed KA, Naqvi SMH, Schell MJ, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Torres-Roca JF, Hoffe SE, Frakes JM. Modeling precision genomic-based radiation dose response in rectal cancer. Future Oncology (London, England). PMID 32686956 DOI: 10.2217/fon-2020-0060  0.01
2020 Kim RD, Chung V, Alese OB, El-Rayes BF, Li D, Al-Toubah TE, Schell MJ, Zhou JM, Mahipal A, Kim BH, Kim DW. A Phase 2 Multi-institutional Study of Nivolumab for Patients With Advanced Refractory Biliary Tract Cancer. Jama Oncology. PMID 32352498 DOI: 10.1001/jamaoncol.2020.0930  0.01
2020 Kumar NB, Pow-Sang J, Spiess P, Dickinson S, Schell MJ. A phase II randomized clinical trial using aglycone isoflavones to treat patients with localized prostate cancer in the pre-surgical period prior to radical prostatectomy. Oncotarget. 11: 1218-1234. PMID 32292572 DOI: 10.18632/oncotarget.27529  0.01
2020 Fowler EE, Berglund A, Schell MJ, Sellers TA, Eschrich S, Heine J. Empirically-Derived Synthetic Populations to Mitigate Small Sample Sizes. Journal of Biomedical Informatics. 103408. PMID 32173502 DOI: 10.1016/J.Jbi.2020.103408  0.01
2020 Yeatman TJ, Schell MJ, Sause W. Assessment of Treatment Cost-effectiveness Using a Colorectal Cancer Mutation Profile. Jama Network Open. 3: e1919991. PMID 32150267 DOI: 10.1001/jamanetworkopen.2019.19991  0.01
2020 Kaplan JL, Powers B, Fan W, Schell MJ, Centeno B, Kim DW, Frakes J, Hoffe SE, Malafa MP, Hodul PJ, Fleming JB, Carballido EM. Predictors of recurrence and implications for overall survival in borderline resectable pancreatic cancer patients treated with total neoadjuvant therapy: A retrospective cohort study. Journal of Clinical Oncology. 38: e16781-e16781. DOI: 10.1200/jco.2020.38.15_suppl.e16781  0.01
2020 Chung CH, Bonomi MR, Steuer CE, Schell MJ, Li J, Johnson M, Masannat J, Hernandez-Prera JC, McMullen C, Wadsworth J, Patel K, Kish JA, Muzaffar J, Kirtane K, Rocco JW, et al. Concurrent cetuximab (CTX) and nivolumab (NIVO) in patients with recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC): Results of phase II study. Journal of Clinical Oncology. 38: 6515-6515. DOI: 10.1200/jco.2020.38.15_suppl.6515  0.01
2020 Thota R, Yang M, Davis T, Schell MJ, Pledger WJ, Yeatman TJ. APC and TP53 as potential biomarkers for EGFR sensitivity in colorectal cancer. Journal of Clinical Oncology. 38: 4094-4094. DOI: 10.1200/jco.2020.38.15_suppl.4094  0.01
2019 DePeralta DK, Ogami T, Zhou JM, Schell MJ, Powers BD, Hodul PJ, Malafa MP, Fleming JB. Completion of adjuvant therapy in patients with resected pancreatic cancer. Hpb : the Official Journal of the International Hepato Pancreato Biliary Association. PMID 31563326 DOI: 10.1016/j.hpb.2019.07.008  0.01
2019 Knepper TC, Montesion M, Russell J, Sokol ES, Frampton GM, Miller VA, Albacker LA, McLeod HL, Eroglu Z, Khushalani NI, Sondak VK, Messina JL, Schell MJ, DeCaprio JA, Tsai KY, et al. The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31399473 DOI: 10.1158/1078-0432.Ccr-18-4159  0.01
2019 Al-Toubah T, Schell M, Cives M, Zhou JM, Soares H, Strosberg JR. A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms. Neuroendocrinology. PMID 31357193 DOI: 10.1159/000502383  0.01
2019 Giuliano AR, Nedjai B, Lorincz AT, Schell MJ, Rahman S, Banwait R, Boulware D, Sirak B, Martin-Gomez L, Abrahamsen M, Isaacs-Soriano KA, Wenig B, Chung CH, Caudell J. Methylation Of Hpv 16 And Epb41l3 In Oral Gargles: Associations With Oropharyngeal Cancer Detection And Tumor Characteristics. International Journal of Cancer. PMID 31304592 DOI: 10.1002/Ijc.32570  0.01
2019 Kim J, Schell MJ. Modified Simon's minimax and optimal two-stage designs for single-arm phase II cancer clinical trials. Oncotarget. 10: 4255-4261. PMID 31303960 DOI: 10.18632/oncotarget.26981  0.16
2019 Yang M, Schell MJ, Loboda A, Nebozhyn M, Li J, Teer JK, Pledger WJ, Yeatman TJ. Repurposing EGFR inhibitor utility in colorectal cancer in mutant APC and TP53 subpopulations. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31015202 DOI: 10.1158/1055-9965.EPI-18-1383  0.01
2019 Martin-Gomez L, Fulp WJ, Schell MJ, Sirak B, Abrahamsen M, Isaacs-Soriano KA, Lorincz A, Wenig B, Chung CH, Caudell JJ, Giuliano AR. Oral gargle-tumor biopsy human papillomavirus (HPV) agreement and associated factors among oropharyngeal squamous cell carcinoma (OPSCC) cases. Oral Oncology. 92: 85-91. PMID 31010629 DOI: 10.1016/J.Oraloncology.2019.03.019  0.01
2019 Creelan BC, Gray JE, Tanvetyanon T, Chiappori AA, Yoshida T, Schell MJ, Antonia SJ, Haura EB. Phase 1 trial of dasatinib combined with afatinib for epidermal growth factor receptor- (EGFR-) mutated lung cancer with acquired tyrosine kinase inhibitor (TKI) resistance. British Journal of Cancer. PMID 30880334 DOI: 10.1038/s41416-019-0428-3  0.04
2019 Atay C, Kwak T, Lavilla-Alonso S, Donthireddy L, Richards AD, Moberg VE, Pilon-Thomas S, Schell MJ, Messina JL, Rebecca VW, Xiao M, Tan J, Zhang G, Weber JS, Herlyn M, et al. BRAF targeting sensitizes resistant melanoma to cytotoxic T cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30765391 DOI: 10.1158/1078-0432.Ccr-18-2725  0.01
2019 Chatzkel JA, Swank J, Ludlow S, Lombardi K, Croft C, Artigas Y, Rodriguez Y, Terraciano T, Hart S, Rembisz J, Johnson E, Schell MJ, Yao J, Zhang J, Fishman MN. Overall responses with coordinated pembrolizumab and high dose IL-2 (5-in-a-row schedule) for therapy of metastatic clear cell renal cancer: A single center, single arm trial. Journal of Clinical Oncology. 37: 657-657. DOI: 10.1200/JCO.2019.37.7_SUPPL.657  0.01
2019 Yuan Z, Ahmed KA, Naqvi SMH, Schell MJ, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim RD, Torres-Roca J, Hoffe SE, Frakes J. Integrated profiling the patterns of pathologic response to neoadjuvant chemoradiation and the genomic-based radiation sensitivity in rectal cancer. Journal of Clinical Oncology. 37: 573-573. DOI: 10.1200/JCO.2019.37.4_SUPPL.573  0.01
2019 Al-Toubah TE, Valone T, Schell MJ, Strosberg JR. Phase II study of ibrutinib in advanced carcinoid and pancreatic neuroendocrine tumors. Journal of Clinical Oncology. 37: 434-434. DOI: 10.1200/JCO.2019.37.4_suppl.434  0.01
2019 Kim RD, Kim DW, Alese OB, Li D, Shah N, Schell MJ, Zhou JM, Chung V. A phase II study of nivolumab in patients with advanced refractory biliary tract cancers (BTC). Journal of Clinical Oncology. 37: 4097-4097. DOI: 10.1200/JCO.2019.37.15_SUPPL.4097  0.01
2019 Yuan Z, Ahmed K, Naqvi S, Schell M, Felder S, Sanchez J, Dessureault S, Imanirad I, Kim R, Torres-Roca J, Hoffe S, Frakes J. Beyond Blind Dose-Escalation: Modeling Precision Genomic-Based Radiation Dose-Response In Rectal Cancer International Journal of Radiation Oncology*Biology*Physics. 105: S159-S160. DOI: 10.1016/j.ijrobp.2019.06.176  0.01
2018 Kumar NB, Dickinson SI, Schell MJ, Manley BJ, Poch MA, Pow-Sang J. Green tea extract for prevention of prostate cancer progression in patients on active surveillance. Oncotarget. 9: 37798-37806. PMID 30701033 DOI: 10.18632/oncotarget.26519  0.01
2018 Rollison DE, Schell MJ, Fenske NA, Cherpelis B, Messina JL, Giuliano AR, Epling-Burnette PK, Hampras S, Amorrortu RP, Balliu J, Vijayan L, Naqvi SMH, Zhao Y, Parab K, McKay-Chopin S, et al. Cutaneous viral infections across two anatomic sites among a cohort of skin cancer screening patients. The Journal of Infectious Diseases. PMID 30260406 DOI: 10.1093/Infdis/Jiy577  0.01
2018 Davis TB, Yang M, Schell MJ, Wang H, Ma L, Pledger WJ, Yeatman TJ. PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation. Scientific Reports. 8: 9296. PMID 29915291 DOI: 10.1038/s41598-018-27584-x  0.01
2018 Yeatman TJ, Davis T, Yang M, Schell MJ, Wang H, Rocha Lima CMS, Pledger J. Molecular rationale for ERK and EGFR inhibition in colorectal cancer. Journal of Clinical Oncology. 36: 679-679. DOI: 10.1200/Jco.2018.36.4_Suppl.679  0.01
2018 Yeatman TJ, Yang M, Schell MJ, Loboda A, Nebozhyn M, Li J, Teer JK, Rocha Lima CMS, Pledger J. Identification of mutation biomarkers underpinning colon cancer sidedness and cetuximab sensitivity. Journal of Clinical Oncology. 36: 629-629. DOI: 10.1200/JCO.2018.36.4_suppl.629  0.01
2018 Knepper TC, Russell JS, Montesion M, Sokol E, Frampton GM, Stephens P, Albacker LA, Schell MJ, DeCaprio JA, Tsai KY, Brohl AS. Comprehensive genomic profiling of advanced Merkel cell carcinoma to reveal insights into immunotherapy response. Journal of Clinical Oncology. 36: 9523-9523. DOI: 10.1200/Jco.2018.36.15_Suppl.9523  0.01
2017 Kumar NB, Patel R, Pow-Sang J, Spiess PE, Salup R, Williams CR, Schell MJ. Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer. Oncotarget. 8: 99093-99103. PMID 29228755 DOI: 10.18632/oncotarget.18858  0.01
2017 Strom T, Harrison LB, Giuliano AR, Schell MJ, Eschrich SA, Berglund A, Fulp W, Thapa R, Coppola D, Kim S, Frakes J, Foekens J, Mulé JJ, Torres-Roca JF. Tumour radiosensitivity is associated with immune activation in solid tumours. European Journal of Cancer (Oxford, England : 1990). 84: 304-314. PMID 28863385 DOI: 10.1016/J.Ejca.2017.08.001  0.16
2017 Blackham AU, H Naqvi SM, Schell MJ, Jin W, Gangi A, Almhanna K, Fontaine JP, Hoffe SE, Frakes J, Venkat P, Pimiento JM. Recurrence patterns and associated factors of locoregional failure following neoadjuvant chemoradiation and surgery for esophageal cancer. Journal of Surgical Oncology. PMID 28833197 DOI: 10.1002/jso.24808  0.01
2017 Kumar NB, Patel R, Pow-Sang J, Spiess PE, Salup R, Williams CR, Schell MJ. Long-term supplementation of decaffeinated green tea extract does not modify body weight or abdominal obesity in a randomized trial of men at high risk for prostate cancer. Oncotarget. PMID 28678746 DOI: 10.18632/oncotarget.18858  0.01
2017 Li J, Smalley I, Schell MJ, Smalley KSM, Chen YA. SinCHet: a MATLAB toolbox for single cell heterogeneity analysis in cancer. Bioinformatics (Oxford, England). PMID 28472395 DOI: 10.1093/bioinformatics/btx297  0.01
2017 Leone A, Diorio G, Sexton W, Schell M, Alexandrow M, Fahey JW, Kumar NB. Sulforaphane for the chemoprevention of bladder cancer: molecular mechanism targeted approach. Oncotarget. PMID 28423681 DOI: 10.18632/Oncotarget.16015  0.01
2017 Gray JE, Tanvetyanon T, Creelan BC, Antonia SJ, Haura EB, Williams CC, Yaseen R, Schell MJ, Godin R, Rix U, Monteiro A. Phase II trial of AZD1775 in combination with carboplatin and paclitaxel in stage IV squamous cell lung cancer (sqNSCLC): Preliminary results. Journal of Clinical Oncology. 35: e20672-e20672. DOI: 10.1200/Jco.2017.35.15_Suppl.E20672  0.01
2017 Khushalani NI, Markowitz J, Eroglu Z, Giuroiu I, Ladanova V, Reiersen P, Rich J, Thapa R, Schell MJ, Sotomayor EM, Weber JS. A phase I trial of panobinostat with ipilimumab in advanced melanoma. Journal of Clinical Oncology. 35: 9547-9547. DOI: 10.1200/Jco.2017.35.15_Suppl.9547  0.01
2016 Kumar NB, Pow-Sang J, Spiess PE, Park J, Salup R, Williams CR, Parnes H, Schell MJ. Randomized, placebo-controlled trial evaluating the safety of one-year administration of green tea catechins. Oncotarget. 7: 70794-70802. PMID 28053292 DOI: 10.18632/oncotarget.12222  0.01
2016 Scott JG, Berglund A, Schell MJ, Mihaylov I, Fulp WJ, Yue B, Welsh E, Caudell JJ, Ahmed K, Strom TS, Mellon E, Venkat P, Johnstone P, Foekens J, Lee J, et al. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. The Lancet. Oncology. PMID 27993569 DOI: 10.1016/S1470-2045(16)30648-9  0.01
2016 Perez LE, Fernandez H, Ayala E, Beato F, Neuger A, Pidala J, Schell MJ, Anasetti C. Visilizumab with tacrolimus and methotrexate for GvHD prevention after allogeneic hematopoietic cell transplantation from mismatched unrelated donors. Bone Marrow Transplantation. PMID 27991896 DOI: 10.1038/Bmt.2016.330  0.01
2016 Omolo B, Yang M, Lo FY, Schell MJ, Austin S, Howard K, Madan A, Yeatman TJ. Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer. Bmc Medical Genomics. 9: 65. PMID 27756306 DOI: 10.1186/s12920-016-0225-2  0.01
2016 Chiappori AA, Otterson GA, Dowlati A, Traynor AM, Horn L, Owonikoko TK, Ross HJ, Hann CL, Abu Hejleh T, Nieva J, Zhao X, Schell M, Sullivan DM. A Randomized Phase II Study of Linsitinib (OSI-906) Versus Topotecan in Patients With Relapsed Small-Cell Lung Cancer. The Oncologist. PMID 27694157 DOI: 10.1634/theoncologist.2016-0220  0.01
2016 Scott JG, Torres-Roca JF, Harrison LB, Berglund AE, Schell M, Mihaylov IB, Fulp WJ, Yue B, Welsh EA, Caudell JJ, Ahmed KA, Strom T, Mellon EA, Venkat PS, Johnstone PA, et al. A Genomic Framework for Precision Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. 96: S215-S216. PMID 27675815 DOI: 10.1016/J.Ijrobp.2016.06.536  0.01
2016 Han G, Schell MJ, Zhang H, Zelterman D, Pusztai L, Adelson K, Hatzis C. Testing violations of the exponential assumption in cancer clinical trials with survival endpoints. Biometrics. PMID 27669414 DOI: 10.1111/Biom.12590  0.01
2016 Schell MJ, Yang M, Teer JK, Lo FY, Madan A, Coppola D, Monteiro AN, Nebozhyn MV, Yue B, Loboda A, Bien-Willner GA, Greenawalt DM, Yeatman TJ. A multigene mutation classification of 468 colorectal cancers reveals a prognostic role for APC. Nature Communications. 7: 11743. PMID 27302369 DOI: 10.1038/ncomms11743  0.24
2016 Weber J, Gibney G, Kudchadkar RR, Yu B, Cheng P, Martinez AJ, Kroeger J, Richards A, McCormick L, Moberg V, Cronin H, Zhao X, Schell M, Chen YA. Phase I/II study of metastatic melanoma patients treated with nivolumab who had progressed after ipilimumab. Cancer Immunology Research. PMID 26873574 DOI: 10.1158/2326-6066.CIR-15-0193  0.01
2015 Schell MJ, Yang M, Missiaglia E, Delorenzi M, Soneson C, Yue B, Nebozhyn M, Loboda A, Bloom G, Yeatman TJ. A composite gene expression signature optimizes prediction of colorectal cancer metastasis and outcome. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26446941 DOI: 10.1158/1078-0432.CCR-15-0143  0.04
2015 Mahipal A, Denson AC, Djulbegovic B, Lush R, Kumar A, Juan TH, Schell MJ, Sullivan DM. Effect of Age on Clinical Outcomes in Phase 1 Trial Participants. Cancer Control : Journal of the Moffitt Cancer Center. 22: 235-41. PMID 26068771  0.08
2015 Smith FO, Yue B, Marzban SS, Walls BL, Carr M, Jackson RS, Puleo CA, Padhya T, Cruse CW, Gonzalez RJ, Sarnaik AA, Schell MJ, DeConti RC, Messina JL, Sondak VK, et al. Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma. Cancer. PMID 26038193 DOI: 10.1002/cncr.29452  0.08
2015 Kim R, Schell MJ, Teer JK, Greenawalt DM, Yang M, Yeatman TJ. Co-evolution of somatic variation in primary and metastatic colorectal cancer may expand biopsy indications in the molecular era. Plos One. 10: e0126670. PMID 25974029 DOI: 10.1371/journal.pone.0126670  0.04
2015 Kumar NB, Pow-Sang J, Egan KM, Spiess PE, Dickinson S, Salup R, Helal M, McLarty JW, Williams CR, Schreiber F, Parnes HL, Sebti S, Kazi A, Kang L, Quinn GP, ... ... Schell MJ, et al. Randomized, Placebo-Controlled Trial of Green Tea Catechins for Prostate Cancer Prevention. Cancer Prevention Research (Philadelphia, Pa.). PMID 25873370 DOI: 10.1158/1940-6207.Capr-14-0324  0.08
2015 Pillai S, Trevino J, Rawal B, Singh S, Kovacs M, Li X, Schell M, Haura E, Bepler G, Chellappan S. β-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition. Cancer Research. 75: 1009-20. PMID 25600647 DOI: 10.1158/0008-5472.Can-14-0681  0.08
2015 Gilbert J, Schell MJ, Zhao X, Murphy B, Tanvetyanon T, Leon ME, Neil Hayes D, Haigentz M, Saba N, Nieva J, Bishop J, Sidransky D, Ravi R, Bedi A, Chung CH. A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma. Oral Oncology. 51: 376-82. PMID 25593015 DOI: 10.1016/j.oraloncology.2014.12.011  0.24
2015 Gibney GT, Kudchadkar RR, DeConti RC, Thebeau MS, Czupryn MP, Tetteh L, Eysmans C, Richards A, Schell MJ, Fisher KJ, Horak CE, Inzunza HD, Yu B, Martinez AJ, Younos I, et al. Safety, correlative markers, and clinical results of adjuvant nivolumab in combination with vaccine in resected high-risk metastatic melanoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 712-20. PMID 25524312 DOI: 10.1158/1078-0432.CCR-14-2468  0.08
2015 Cives M, Kunz PL, Morse B, Coppola D, Schell MJ, Campos T, Nguyen PT, Nandoskar P, Khandelwal V, Strosberg JR. Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors. Endocrine-Related Cancer. 22: 1-9. PMID 25376618 DOI: 10.1530/ERC-14-0360  0.08
2015 Kim R, Schell MJ, Teer JK, Greenawalt DM, Yang M, Yeatman TJ. Co-evolution of somatic variation in primary and metastatic colorectal cancer may expand biopsy indications in the molecular era Plos One. 10. DOI: 10.1371/journal.pone.0126670  0.24
2015 Kothari N, Yue B, Teer JK, Schell MJ, Kim RD. Prognostic and predictive values of APC and WNT pathway mutations in MSS colorectal cancers. Journal of Clinical Oncology. 33: 652-652. DOI: 10.1200/JCO.2015.33.3_SUPPL.652  0.01
2015 Byer JE, Kothari N, Juan T, Teer JK, Schell MJ, Shibata D, Kim RD. Prognostic value of RAS, BRAF, and PIK3CA mutations in early-stage colorectal cancer. Journal of Clinical Oncology. 33: 594-594. DOI: 10.1200/JCO.2015.33.3_SUPPL.594  0.01
2015 Weber JS, Gibney GT, Yu B, Cheng P, Martinez AJ, Kroeger J, Freed J, Richards A, Zhao X, Schell MJ. Survival, biomarker, and toxicity analysis of nivolumab (NIVO) in patients that progressed on ipilimumab (IPI). Journal of Clinical Oncology. 33: 9055-9055. DOI: 10.1200/JCO.2015.33.15_SUPPL.9055  0.01
2015 Kumar NB, Pow-Sang J, Egan K, Spiess PE, Dickinson SI, Salup R, Helal M, McLarty J, Williams CR, Schreiber FJ, Parnes H, Sebti S, Kazi A, Kang L, Quinn GP, ... ... Schell MJ, et al. Effect of green tea catechins in prostate cancer chemoprevention. Journal of Clinical Oncology. 33: 1572-1572. DOI: 10.1200/Jco.2015.33.15_Suppl.1572  0.01
2015 Mahipal A, Denson AC, Djulbegovic B, Lush R, Kumar A, Juan TH, Schell MJ, Sullivan DM. Effect of age on clinical outcomes in phase 1 trial participants Cancer Control. 22: 235-241.  0.08
2014 Kumar NB, Quinn GP, Alexandrow MG, Jhanelle G, Michael S, Steve S, Haura EB. Chemoprevention Trial Feasibility Using Botanicals in Exceptionally High Risk Populations for Lung Cancer. Journal of Clinical Trials. 4. PMID 26101725 DOI: 10.4172/2167-0870.1000180  0.01
2014 Kothari N, Schell MJ, Teer JK, Yeatman T, Shibata D, Kim R. Comparison of KRAS mutation analysis of colorectal cancer samples by standard testing and next-generation sequencing. Journal of Clinical Pathology. 67: 764-7. PMID 25004944 DOI: 10.1136/Jclinpath-2014-202405  0.08
2014 Rao NG, Trotti A, Kim J, Schell MJ, Zhao X, Amdur RJ, Brizel DM, Chambers MS, Caudell JJ, Miyamoto C, Rosenthal DI. Phase II multicenter trial of Caphosol for the reduction of mucositis in patients receiving radiation therapy for head and neck cancer. Oral Oncology. 50: 765-9. PMID 24954065 DOI: 10.1016/J.Oraloncology.2014.06.001  0.08
2014 Lengacher CA, Reich RR, Kip KE, Barta M, Ramesar S, Paterson CL, Moscoso MS, Carranza I, Budhrani PH, Kim SJ, Park HY, Jacobsen PB, Schell MJ, Jim HS, Post-White J, et al. Influence of mindfulness-based stress reduction (MBSR) on telomerase activity in women with breast cancer (BC). Biological Research For Nursing. 16: 438-47. PMID 24486564 DOI: 10.1177/1099800413519495  0.08
2014 Reich RR, Lengacher CA, Kip KE, Shivers SC, Schell MJ, Shelton MM, Widen RH, Newton C, Barta MK, Paterson CL, Farias JR, Cox CE, Klein TW. Baseline immune biomarkers as predictors of MBSR(BC) treatment success in off-treatment breast cancer patients. Biological Research For Nursing. 16: 429-37. PMID 24477514 DOI: 10.1177/1099800413519494  0.08
2014 Gray JE, Haura E, Chiappori A, Tanvetyanon T, Williams CC, Pinder-Schenck M, Kish JA, Kreahling J, Lush R, Neuger A, Tetteh L, Akar A, Zhao X, Schell MJ, Bepler G, et al. A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 1644-55. PMID 24429877 DOI: 10.1158/1078-0432.CCR-13-2235  0.08
2014 Han G, Schell MJ, Kim J. Improved survival modeling in cancer research using a reduced piecewise exponential approach. Statistics in Medicine. 33: 59-73. PMID 23900779 DOI: 10.1002/sim.5915  0.08
2014 Kothari N, Kim RD, Gibbs P, Yeatman TJ, Schell MJ, Desai J, Tie J, Lipton LR, Jorissen RN, Wong H, Sieber O, Day F, Faragher I, Jones I, Tran B. Regular aspirin (ASA) use and survival in patients with PIK3CA-mutated metastatic colorectal cancer (CRC). Journal of Clinical Oncology. 32: 386-386. DOI: 10.1200/jco.2014.32.3_suppl.386  0.01
2013 Li J, Bennett K, Stukalov A, Fang B, Zhang G, Yoshida T, Okamoto I, Kim JY, Song L, Bai Y, Qian X, Rawal B, Schell M, Grebien F, Winter G, et al. Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. Molecular Systems Biology. 9: 705. PMID 24189400 DOI: 10.1038/Msb.2013.61  0.08
2013 Etzkorn JR, Parikh RP, Marzban SS, Law K, Davis AH, Rawal B, Schell MJ, Sondak VK, Messina JL, Rendina LE, Zager JS, Lien MH. Identifying risk factors using a skin cancer screening program. Cancer Control : Journal of the Moffitt Cancer Center. 20: 248-54. PMID 24077401  0.08
2013 Creelan BC, Antonia S, Noyes D, Hunter TB, Simon GR, Bepler G, Williams CC, Tanvetyanon T, Haura EB, Schell MJ, Chiappori A. Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 442-50. PMID 23994887 DOI: 10.1097/CJI.0b013e3182a80237  0.08
2013 Bepler G, Williams C, Schell MJ, Chen W, Zheng Z, Simon G, Gadgeel S, Zhao X, Schreiber F, Brahmer J, Chiappori A, Tanvetyanon T, Pinder-Schenck M, Gray J, Haura E, et al. Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2404-12. PMID 23690416 DOI: 10.1200/JCO.2012.46.9783  0.08
2013 Gray JE, Altiok S, Alexandrow MG, Walsh FW, Chen J, Schell MJ, Tai DF, Bepler G. Phase 2 randomized study of enzastaurin (LY317615) for lung cancer prevention in former smokers. Cancer. 119: 1023-32. PMID 23065656 DOI: 10.1002/Cncr.27836  0.08
2013 Kothari N, Yeatman TJ, Schell MJ, Greenawalt D, Hardwick J, Nebozhyn M, Loboda A, Dai H, Kim RD. Concordance of KRAS mutation detection between Illumina next generation gene sequencing (NGS) and CLIA-approved, clinical assays in metastatic colorectal cancer (mCRC). Journal of Clinical Oncology. 31: 345-345. DOI: 10.1200/jco.2013.31.4_suppl.345  0.01
2013 Bepler G, Williams CC, Schell MJ, Chen W, Zheng Z, Simon GR, Gadgeel SM, Zhao X, Schreiber FJ, Brahmer JR, Chiappori A, Tanvetyanon T, Pinder MC, Gray JE, Haura EB, et al. Molecular analysis-directed, international, phase III trial in patients with advanced non-small-cell lung cancer. Journal of Clinical Oncology. 31: 8001-8001. DOI: 10.1200/JCO.2013.31.15_SUPPL.8001  0.01
2013 Gilbert J, Schell MJ, Zhao X, Murphy BA, Tanvetyanon T, Hayes DN, Haigentz M, Saba NF, Nieva JJ, Perez J, Bishop JA, Chung CH. Cetuximab with or without sorafenib in recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN). Journal of Clinical Oncology. 31: 6047-6047. DOI: 10.1200/JCO.2013.31.15_SUPPL.6047  0.01
2013 Kothari N, Yeatman TJ, Fisher K, Schell MJ, Kim RD. Association of aspirin use with improved 5-year survival in colorectal cancer patients with PIK3CA mutation. Journal of Clinical Oncology. 31: 3644-3644. DOI: 10.1200/jco.2013.31.15_suppl.3644  0.01
2012 Kumar N, Crocker T, Smith T, Connors S, Pow-Sang J, Spiess PE, Egan K, Quinn G, Schell M, Sebti S, Kazi A, Chuang T, Salup R, Helal M, Zagaja G, et al. Prostate Cancer Chemoprevention Targeting Men with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Small Acinar Proliferation (ASAP): Model for Trial Design and Outcome Measures. Journal of Clinical Trials. 2. PMID 24533253 DOI: 10.4172/Jctr.1000105  0.01
2012 Han G, Schell MJ, Kim J. Comparing Two Exponential Distributions Using the Exact Likelihood Ratio Test. Statistics in Biopharmaceutical Research. 4: 348-356. PMID 23814641 DOI: 10.1080/19466315.2012.698945  0.08
2012 Messina JL, Fenstermacher DA, Eschrich S, Qu X, Berglund AE, Lloyd MC, Schell MJ, Sondak VK, Weber JS, Mulé JJ. 12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy? Scientific Reports. 2: 765. PMID 23097687 DOI: 10.1038/Srep00765  0.08
2012 Knapp CF, Sayegh Z, Schell MJ, Rawal B, Ochoa T, Sondak VK, Messina JL. Expression of CXCR4, E-cadherin, Bcl-2, and survivin in Merkel cell carcinoma: an immunohistochemical study using a tissue microarray. The American Journal of Dermatopathology. 34: 592-6. PMID 22814318 DOI: 10.1097/DAD.0b013e31823e25d3  0.08
2012 Strosberg JR, Yeatman T, Weber J, Coppola D, Schell MJ, Han G, Almhanna K, Kim R, Valone T, Jump H, Sullivan D. A phase II study of RO4929097 in metastatic colorectal cancer. European Journal of Cancer (Oxford, England : 1990). 48: 997-1003. PMID 22445247 DOI: 10.1016/J.Ejca.2012.02.056  0.24
2012 Strosberg JR, Weber JM, Choi J, Campos TL, Valone TL, Han G, Schell MJ, Kvols LK. A phase II clinical trial of sunitinib following hepatic transarterial embolization for metastatic neuroendocrine tumors. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 23: 2335-41. PMID 22317769 DOI: 10.1093/annonc/mdr614  0.08
2012 Simon GR, Schell MJ, Begum M, Kim J, Chiappori A, Haura E, Antonia S, Bepler G. Preliminary indication of survival benefit from ERCC1 and RRM1-tailored chemotherapy in patients with advanced nonsmall cell lung cancer: evidence from an individual patient analysis. Cancer. 118: 2525-31. PMID 22028294 DOI: 10.1002/cncr.26522  0.08
2012 Kumar NB, Quinn GP, Crocker T, Alexandrow M, Gray JE, Estrella T, Schell MJ, Sutton S, Haura EB. Assessment of feasibility and willingness of former heavy smokers to participate in chemoprevention trials to prevent lung cancer. Journal of Clinical Oncology. 30: e21155-e21155. DOI: 10.1200/Jco.2012.30.15_Suppl.E21155  0.01
2012 Creelan BC, Antonia S, Noyes D, Hunter TB, Simon GR, Bepler G, Williams CC, Tanvetyanon T, Haura EB, Schell MJ, Dessureault S, Chiappori A. Phase II trial of a GM-CSF-producing and CD40L-expressing cell line combined with allogeneic tumor antigen as a novel vaccine for metastatic lung adenocarcinoma. Journal of Clinical Oncology. 30: 2559-2559. DOI: 10.1200/JCO.2012.30.15_SUPPL.2559  0.01
2012 Schell MJ, Haura EB, Kim J, Han G, Simon GR. How to run survival-endpoint phase II trials with 25% to 40% fewer patients. Journal of Clinical Oncology. 30: 2544-2544. DOI: 10.1200/jco.2012.30.15_suppl.2544  0.01
2012 Pidala J, Kim J, Schell M, Hillgruber R, Nye V, Ayala E, Alsina M, Betts B, Bookout R, Fernandez H, Field T, Locke F, Nishihori T, Ochoa J, Perez L, et al. Effectiveness of Unrelated Donor Allogeneic Hematopoietic Cell Transplantation: Results of a Donor Vs. No Donor Analysis Biology of Blood and Marrow Transplantation. 18: S267-S268. DOI: 10.1016/J.Bbmt.2011.12.528  0.01
2011 Pillai S, Rizwani W, Li X, Rawal B, Nair S, Schell MJ, Bepler G, Haura E, Coppola D, Chellappan S. ID1 facilitates the growth and metastasis of non-small cell lung cancer in response to nicotinic acetylcholine receptor and epidermal growth factor receptor signaling. Molecular and Cellular Biology. 31: 3052-67. PMID 21606196 DOI: 10.1128/Mcb.01311-10  0.08
2011 Bepler G, Olaussen KA, Vataire AL, Soria JC, Zheng Z, Dunant A, Pignon JP, Schell MJ, Fouret P, Pirker R, Filipits M, Brambilla E. ERCC1 and RRM1 in the international adjuvant lung trial by automated quantitative in situ analysis. The American Journal of Pathology. 178: 69-78. PMID 21224045 DOI: 10.1016/j.ajpath.2010.11.029  0.08
2011 Djulbegovic B, Kumar A, Magazin A, Schroen AT, Soares H, Hozo I, Clarke M, Sargent D, Schell MJ. Optimism bias leads to inconclusive results-an empirical study. Journal of Clinical Epidemiology. 64: 583-93. PMID 21163620 DOI: 10.1016/j.jclinepi.2010.09.007  0.08
2011 Mahmood ST, Agresta S, Vigil CE, Zhao X, Han G, D'Amato G, Calitri CE, Dean M, Garrett C, Schell MJ, Antonia S, Chiappori A. Phase II study of sunitinib malate, a multitargeted tyrosine kinase inhibitor in patients with relapsed or refractory soft tissue sarcomas. Focus on three prevalent histologies: leiomyosarcoma, liposarcoma and malignant fibrous histiocytoma. International Journal of Cancer. Journal International Du Cancer. 129: 1963-9. PMID 21154746 DOI: 10.1002/ijc.25843  0.08
2011 Turaga KK, Malafa MP, Jacobsen PB, Schell MJ, Sarr MG. Suicide in patients with pancreatic cancer. Cancer. 117: 642-7. PMID 20824626 DOI: 10.1002/cncr.25428  0.08
2011 Schell MJ. Re: Letters to the editor American Statistician. 65: 140. DOI: 10.1198/tast.2011.11011  0.01
2011 Holkova B, Perkins EB, Sokol L, Richards KL, Parekh S, Elstrom R, Badros AZ, Espinoza-Delgado I, Schell MJ, Kimball A, Tombes MB, Shrader E, Sankala H, Coppola D, Kmieciak M, et al. A Phase II Trial of Bortezomib and Vorinostat in Mantle Cell Lymphoma and Diffuse Large B-Cell Lymphoma Blood. 118: 779-779. DOI: 10.1182/BLOOD.V118.21.779.779  0.01
2011 Rao N, Trotti A, Kim J, Schell M, Zhao X, Amdur R, Brizel D, Chambers M, Miyamoto C, Rosenthal D. Phase II Multicenter Trial of Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer International Journal of Radiation Oncology*Biology*Physics. 81: S75. DOI: 10.1016/J.Ijrobp.2011.06.150  0.01
2010 Haura EB, Tanvetyanon T, Chiappori A, Williams C, Simon G, Antonia S, Gray J, Litschauer S, Tetteh L, Neuger A, Song L, Rawal B, Schell MJ, Bepler G. Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1387-94. PMID 20142592 DOI: 10.1200/JCO.2009.25.4029  0.08
2010 Chiappori AA, Zheng Z, Chen T, Rawal B, Schell MJ, Mullaney BP, Bepler G. Features of potentially predictive biomarkers of chemotherapeutic efficacy in small cell lung cancer. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 5: 484-90. PMID 20107425 DOI: 10.1097/JTO.0b013e3181ccb27b  0.24
2010 Chen JJ, Roberson PK, Schell MJ. The false discovery rate: a key concept in large-scale genetic studies. Cancer Control : Journal of the Moffitt Cancer Center. 17: 58-62. PMID 20010520  0.24
2010 Gergis U, Markey K, Greene J, Kharfan-Dabaja M, Field T, Wetzstein G, Schell MJ, Huang Y, Anasetti C, Perkins J. Voriconazole provides effective prophylaxis for invasive fungal infection in patients receiving glucocorticoid therapy for GVHD. Bone Marrow Transplantation. 45: 662-7. PMID 19684623 DOI: 10.1038/bmt.2009.210  0.08
2010 Schell MJ. Identifying key statistical papers from 1985 to 2002 using citation data for applied biostatisticians American Statistician. 64: 310-317. DOI: 10.1198/tast.2010.08250  0.08
2009 Simon GR, Schell MJ, Begum M, Kim J, Chiappori A, Haura E, Antonia S. Evidence for long-term survival in a sizeable proportion of good performance status (PS) patients (pts) with advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: e19016. PMID 27962624 DOI: 10.1200/jco.2009.27.15_suppl.e19016  0.01
2009 Mhaskar RS, Kumar A, Soares H, Schell M, Djulbegovic B. Does quality of treatment-related harms reporting affect conclusions about superiority of treatment? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 6607. PMID 27961736 DOI: 10.1200/Jco.2009.27.15_Suppl.6607  0.01
2009 Reynolds C, Obasaju C, Schell MJ, Li X, Zheng Z, Boulware D, Caton JR, Demarco LC, O'Rourke MA, Shaw Wright G, Boehm KA, Asmar L, Bromund J, Peng G, Monberg MJ, et al. Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 5808-15. PMID 19884554 DOI: 10.1200/JCO.2009.21.9766  0.24
2009 Lee JH, Schell MJ, Roetzheim R. Analysis of group randomized trials with multiple binary endpoints and small number of groups. Plos One. 4: e7265. PMID 19844579 DOI: 10.1371/Journal.Pone.0007265  0.24
2009 Gao J, Zheng Z, Rawal B, Schell MJ, Bepler G, Haura EB. Mirk/Dyrk1B, a novel therapeutic target, mediates cell survival in non-small cell lung cancer cells. Cancer Biology & Therapy. 8: 1671-9. PMID 19633423 DOI: 10.4161/cbt.8.17.9322  0.24
2009 Guo JP, Shu SK, He L, Lee YC, Kruk PA, Grenman S, Nicosia SV, Mor G, Schell MJ, Coppola D, Cheng JQ. Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. The American Journal of Pathology. 175: 324-33. PMID 19497997 DOI: 10.2353/Ajpath.2009.080767  0.24
2009 Barami K, Sloan AE, Rojiani A, Schell MJ, Staller A, Brem S. Relationship of gliomas to the ventricular walls. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia. 16: 195-201. PMID 19097905 DOI: 10.1016/J.Jocn.2008.03.006  0.24
2009 Perkins J, Alsina M, Anasetti C, Ayala E, Fernandez H, Kharfan-Dabaja M, Ochoa-Bayona L, Perez L, Raychaudhuri J, Sullivan D, Kim J, Schell M, Field T. A Randomized, Controlled Trial of Graft-Versus-Host Disease (GVHD) Prophylaxis Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate: Analysis of GVHD, Relapse and Survival Biology of Blood and Marrow Transplantation. 15: 87. DOI: 10.1016/J.BBMT.2008.12.271  0.01
2009 Paoletti C, Balducci L, Alsina M, Boler I, Popa M, Extermann M, Lara-Rivera S, Raychaudhury J, Anasetti C, Fernandez H, Sullivan D, Dalton W, Field T, Ayala E, Kharfan-Dabaja M, ... ... Schell M, et al. Autologous Stem Cell Transplantation (ASCT) In Patients Aged ≥65 Years With Multiple Myeloma: Moffitt Cancer Center Experience Biology of Blood and Marrow Transplantation. 15: 68. DOI: 10.1016/j.bbmt.2008.12.210  0.01
2009 Lee JH, Miladinovic B, Schell MJ. Analysis of two group comparisons: A practical guide Medical Problems of Performing Artists. 24: 166-169.  0.24
2008 Bepler G, Li X, Schell M, Zheng Z, Boulware D, Obasaju CK, Reynolds C. Predictive value of RRM1 and ERCC1 protein levels in a prospective community-based trial of gemcitabine/carboplatin (GC) vs gemcitabine (G) alone. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 8033. PMID 27949054 DOI: 10.1200/jco.2008.26.15_suppl.8033  0.01
2008 Chen DT, Schell MJ, Chen JJ, Fulp WJ, Eschrich S, Yeatman T. A predictive risk probability approach for microarray data with survival as an endpoint. Journal of Biopharmaceutical Statistics. 18: 841-52. PMID 18781520 DOI: 10.1080/10543400802277967  0.24
2008 Hozo I, Schell MJ, Djulbegovic B. Decision-making when data and inferences are not conclusive: risk-benefit and acceptable regret approach. Seminars in Hematology. 45: 150-9. PMID 18582621 DOI: 10.1053/j.seminhematol.2008.04.006  0.24
2008 Zheng Z, Li X, Schell MJ, Chen T, Boulware D, Robinson L, Sommers E, Bepler G. Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer. Cancer. 112: 2765-73. PMID 18442042 DOI: 10.1002/cncr.23491  0.24
2008 Tanvetyanon T, Robinson LA, Schell MJ, Strong VE, Kapoor R, Coit DG, Bepler G. Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1142-7. PMID 18309950 DOI: 10.1200/JCO.2007.14.2091  0.24
2008 Simon GR, Extermann M, Chiappori A, Williams CC, Begum M, Kapoor R, Haura EB, Ismail-Khan R, Schell MJ, Antonia SJ, Bepler G. Phase 2 trial of docetaxel and gefitinib in the first-line treatment of patients with advanced nonsmall-cell lung cancer (NSCLC) who are 70 years of age or older. Cancer. 112: 2021-9. PMID 18300255 DOI: 10.1002/cncr.23360  0.24
2008 Ghosh M, Schell MJ. A conversation with pranab kumar sen Statistical Science. 23: 548-564. DOI: 10.1214/08-Sts255  0.24
2008 Magazin A, Kumar A, Soares H, Schell M, Hozo I, Djulbegovic B. Expectation Bias-the Main Culprit for Large Number of Inconclusive Randomized Controlled Trials in Hematological Malignancies Blood. 112: 671-671. DOI: 10.1182/BLOOD.V112.11.671.671  0.01
2008 Paoletti C, Balducci L, Boler I, Popa-McKiver M, Externann M, Raychaudury J, Anasetti C, Fernandez HF, Sullivan D, Dalton WS, Field T, Ayala E, Kharfan-Dabaja MA, Perez L, Perkins J, ... ... Schell M, et al. Age Is the Strongest Independent Prognostic Factor in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation: Moffitt Cancer Center Experience Blood. 112: 4435-4435. DOI: 10.1182/blood.v112.11.4435.4435  0.01
2008 Perkins J, Alsina M, Anasetti C, Ayala E, Fernandez HF, Kharfan-Dabaja M, Ochoa-Bayona JL, Perez L, Raychaudhuri J, Sullivan D, Kim J, Schell M, Field T. A Randomized, Controlled Trial of Graft-Versus-Host Disease (GVHD) Prophylaxis Comparing Tacrolimus and Mycophenolate Mofetil to Tacrolimus and Methotrexate: Analysis of GVHD, Relapse and Survival. Blood. 112: 2235-2235. DOI: 10.1182/blood.v112.11.2235.2235  0.01
2008 Singh B, Halabi S, Schell MJ. Sample size selection in clinical trials when population means are subject to a partial order: One-sided ordered alternatives Journal of Applied Statistics. 35: 583-600. DOI: 10.1080/02664760801924780  0.24
2007 Schell MJ, Yankaskas BC, Ballard-Barbash R, Qaqish BF, Barlow WE, Rosenberg RD, Smith-Bindman R. Evidence-based target recall rates for screening mammography. Radiology. 243: 681-9. PMID 17517927 DOI: 10.1148/Radiol.2433060372  0.24
2007 Pavic D, Schell MJ, Dancel RD, Sultana S, Lin L, Sejpal SV, Pisano ED. Comparison of three methods to increase knowledge about breast cancer and breast cancer screening in screening mammography patients. Academic Radiology. 14: 553-60. PMID 17434069 DOI: 10.1016/J.Acra.2007.01.011  0.24
2007 Sullivan D, Alsina M, Anasetti C, Field T, Kharfan-Dabaja M, Fernandez H, Dalton W, Ayala E, Raychaudhuri J, Perez L, Perkins J, Schell M, McIsaac C, Maddox B, Gump J, et al. Phase I/II Trial of High-Dose Melphalan (M) and Topotecan (T) Followed by Autologous Stem Cell Rescue in Patients ≤ 60 and > 60 Years of Age with Multiple Myeloma (MM). Blood. 110: 943-943. DOI: 10.1182/Blood.V110.11.943.943  0.01
2007 Dessureault S, Noyes D, Tao J, Moscinski L, Schell M, Antonia SJ, Sotomayor EM. Bystander-Based Immunotherapy for Patients with Mantle Cell Lymphoma (MCL): Proof of Principle. Blood. 110: 4483-4483. DOI: 10.1182/Blood.V110.11.4483.4483  0.01
2006 Turner JG, Gump JL, Zhang C, Cook JM, Marchion D, Hazlehurst L, Munster P, Schell MJ, Dalton WS, Sullivan DM. ABCG2 expression, function, and promoter methylation in human multiple myeloma. Blood. 108: 3881-9. PMID 16917002 DOI: 10.1182/Blood-2005-10-009084  0.24
2006 Graham DK, Salzberg DB, Kurtzberg J, Sather S, Matsushima GK, Keating AK, Liang X, Lovell MA, Williams SA, Dawson TL, Schell MJ, Anwar AA, Snodgrass HR, Earp HS. Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 2662-9. PMID 16675557 DOI: 10.1158/1078-0432.Ccr-05-2208  0.24
2006 Stinchcombe TE, Choi J, Schell MJ, Mears A, Jones PE, Nachtsheim RV, Socinski MA. Carboplatin-based chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status. Lung Cancer (Amsterdam, Netherlands). 51: 237-43. PMID 16378657 DOI: 10.1016/J.Lungcan.2005.10.018  0.24
2006 Schell MJ. Teaching statistics using baseball The Mathematical Intelligencer. 28: 66-67. DOI: 10.1007/BF02987010  0.01
2005 Ivanova A, Qaqish BF, Schell MJ. Continuous toxicity monitoring in phase II trials in oncology. Biometrics. 61: 540-5. PMID 16011702 DOI: 10.1111/J.1541-0420.2005.00311.X  0.24
2005 Titus MA, Schell MJ, Lih FB, Tomer KB, Mohler JL. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4653-7. PMID 16000557 DOI: 10.1158/1078-0432.CCR-05-0525  0.24
2005 Titus MA, Gregory CW, Ford OH, Schell MJ, Maygarden SJ, Mohler JL. Steroid 5alpha-reductase isozymes I and II in recurrent prostate cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4365-71. PMID 15958619 DOI: 10.1158/1078-0432.CCR-04-0738  0.24
2005 Kondo S, Wakisaka N, Schell MJ, Horikawa T, Sheen TS, Sato H, Furukawa M, Pagano JS, Yoshizaki T. Epstein-Barr virus latent membrane protein 1 induces the matrix metalloproteinase-1 promoter via an Ets binding site formed by a single nucleotide polymorphism: enhanced susceptibility to nasopharyngeal carcinoma. International Journal of Cancer. Journal International Du Cancer. 115: 368-76. PMID 15688379 DOI: 10.1002/ijc.20849  0.24
2005 Hensing TA, Schell MJ, Lee JH, Socinski MA. Factors associated with the likelihood of receiving second line therapy for advanced non-small cell lung cancer. Lung Cancer (Amsterdam, Netherlands). 47: 253-9. PMID 15639724 DOI: 10.1016/J.Lungcan.2004.07.040  0.24
2005 Titus M, Song L, Schell M, Tomer K, Mohler J. 413: Androgen Tissue Levels in Recurrent Prostate Cancer using Liquid Chromatography Tandem Mass Spectrometry Journal of Urology. 173: 113-113. DOI: 10.1016/S0022-5347(18)34666-4  0.01
2004 Yankaskas BC, Schell MJ, Miglioretti DL. Recall and detection rates in screening mammography. Cancer. 101: 2710-1; author reply. PMID 15499596 DOI: 10.1002/Cncr.20683  0.24
2004 Mohler JL, Gaston KE, Moore DT, Schell MJ, Cohen BL, Weaver C, Petrusz P. Racial differences in prostate androgen levels in men with clinically localized prostate cancer. The Journal of Urology. 171: 2277-80. PMID 15126802 DOI: 10.1097/01.ju.0000127739.88383.79  0.24
2004 Titus MA, Gregory CW, Smitherman AB, Schell MJ, Funkhouser WK, Lazier CB, Mohler JL. 1089: Steroid 5α-Reductase Isozymes I and II in Recurrent Prostate Cancer Journal of Urology. 171: 287-287. DOI: 10.1016/s0022-5347(18)38326-5  0.01
2003 Hensing TA, Peterman AH, Schell MJ, Lee JH, Socinski MA. The impact of age on toxicity, response rate, quality of life, and survival in patients with advanced, Stage IIIB or IV nonsmall cell lung carcinoma treated with carboplatin and paclitaxel. Cancer. 98: 779-88. PMID 12910523 DOI: 10.1002/Cncr.11548  0.24
2003 Abrahamson PE, Dunlap LA, Amamoo MA, Schell MJ, Braeuning MP, Pisano ED. Factors predicting successful needle-localized breast biopsy. Academic Radiology. 10: 601-6. PMID 12809412 DOI: 10.1016/S1076-6332(03)80077-6  0.24
2002 McHale MT, Berman ML, Keefe KA, Schell MJ, Peng YM, Monk BJ. Influence of serum and tissue micronutrient levels on the regression of untreated cervical intraepithelial neoplasia 2 and 3. Journal of Lower Genital Tract Disease. 6: 220-4. PMID 17051026  0.24
2002 Bloedon LT, Jeffcoat AR, Lopaczynski W, Schell MJ, Black TM, Dix KJ, Thomas BF, Albright C, Busby MG, Crowell JA, Zeisel SH. Safety and pharmacokinetics of purified soy isoflavones: single-dose administration to postmenopausal women. The American Journal of Clinical Nutrition. 76: 1126-37. PMID 12399289 DOI: 10.1093/Ajcn/76.5.1126  0.24
2002 Socinski MA, Schell MJ, Bakri K, Peterman A, Lee JH, Unger P, Yates S, Hudgens S, Kies MS. Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel. Cancer. 95: 1265-73. PMID 12216094 DOI: 10.1002/Cncr.10835  0.24
2002 Socinski MA, Schell MJ, Peterman A, Bakri K, Yates S, Gitten R, Unger P, Lee J, Lee JH, Tynan M, Moore M, Kies MS. Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 1335-43. PMID 11870177 DOI: 10.1200/Jco.20.5.1335  0.24
2002 Schell MJ. Curve Ball: Baseball, Statistics, and the Role of Chance in the Game Journal of the American Statistical Association. 97: 919-919. DOI: 10.1198/016214502760301174  0.01
2001 Poole ME, Sailer SL, Rosenman JG, Tepper JE, Weissler MC, Shockley WW, Yarbrough WG, Pillsbury HC, Schell MJ, Bernard SA. Chemoradiation for locally advanced squamous cell carcinoma of the head and neck for organ preservation and palliation. Archives of Otolaryngology--Head & Neck Surgery. 127: 1446-50. PMID 11735812  0.24
2001 Pisano ED, Britt GG, Lin Y, Schell MJ, Burns CB, Brown ME. Factors affecting phantom scores at annual mammography facility inspections by the U.S. Food and Drug Administration. Academic Radiology. 8: 864-70. PMID 11724041 DOI: 10.1016/S1076-6332(03)80765-1  0.24
2001 Illig KA, Williams JP, Lyden SP, Hernady E, Soni A, Davies MG, Schell M, Okunieff P, Rubin P, Green RM. External beam irradiation for inhibition of intimal hyperplasia following prosthetic bypass: preliminary results. Annals of Vascular Surgery. 15: 533-8. PMID 11665436 DOI: 10.1007/s10016-001-0004-0  0.04
2001 Keefe KA, Schell MJ, Brewer C, McHale M, Brewster W, Chapman JA, Rose GS, McMeeken DS, Lagerberg W, Peng YM, Wilczynski SP, Anton-Culver H, Meyskens FL, Berman ML. A randomized, double blind, Phase III trial using oral beta-carotene supplementation for women with high-grade cervical intraepithelial neoplasia. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 10: 1029-35. PMID 11588128  0.24
2001 Socinski MA, Rosenman JG, Halle J, Schell MJ, Lin Y, Russo S, Patriciarivera M, Clark J, Limentani S, Fraser R, Mitchell W, Detterbeck FC. Hyaluronan content in pleural fluid as a prognostic factor in patients with malignant pleural mesothelioma Cancer. 92: 1224-1230. PMID 11571736 DOI: 10.1002/1097-0142(20010901)92:5<1224::AID-CNCR1441>3.0.CO;2-U  0.24
2001 Socinski MA, Rosenman JG, Halle J, Schell MJ, Lin Y, Russo S, Rivera MP, Clark J, Limentani S, Fraser R, Mitchell W, Detterbeck FC. Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified phase I/II trial. Cancer. 92: 1213-23. PMID 11571735 DOI: 10.1002/1097-0142(20010901)92:5<1213::AID-CNCR1440>3.0.CO;2-0  0.01
2001 Godley PA, Rathore SS, Kshirsagar AV, Amamoo MA, Schell MJ, Freeman J, Harris RP. Retrospective classification of prostate-specific antigen tests: differentiating screening from diagnostic clinical encounters. Journal of Clinical Epidemiology. 54: 884-8. PMID 11520647 DOI: 10.1016/S0895-4356(01)00364-X  0.24
2001 Yankaskas BC, Cleveland RJ, Schell MJ, Kozar R. Association of recall rates with sensitivity and positive predictive values of screening mammography. Ajr. American Journal of Roentgenology. 177: 543-9. PMID 11517044 DOI: 10.2214/ajr.177.3.1770543  0.24
2001 Yankaskas BC, Schell MJ, Bird RE, Desrochers DA. Reassessment of breast cancers missed during routine screening mammography: a community-based study. Ajr. American Journal of Roentgenology. 177: 535-41. PMID 11517043 DOI: 10.2214/ajr.177.3.1770535  0.24
2001 Charles MJ, Schell MJ, Willman E, Gross HB, Lin Y, Sonnenberg S, Graham ML. Organochlorines and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in cancerous and noncancerous breast tissue: do the data support the hypothesis that oxidative DNA damage caused by organochlorines affects breast cancer? Archives of Environmental Contamination and Toxicology. 41: 386-95. PMID 11503078 DOI: 10.1007/s002440010264  0.24
2001 Duell EJ, Millikan RC, Savitz DA, Schell MJ, Newman B, Tse CJ, Sandler DP. Reproducibility of reported farming activities and pesticide use among breast cancer cases and controls. A comparison of two modes of data collection. Annals of Epidemiology. 11: 178-85. PMID 11248581 DOI: 10.1016/S1047-2797(00)00208-8  0.24
2001 O'Malley MS, Earp JA, Hawley ST, Schell MJ, Mathews HF, Mitchell J. The association of race/ethnicity, socioeconomic status, and physician recommendation for mammography: who gets the message about breast cancer screening? American Journal of Public Health. 91: 49-54. PMID 11189825 DOI: 10.2105/Ajph.91.1.49  0.24
2000 Gillenwater HH, Tynan M, Natoli S, Schell MJ, Socinski MA. Second-line gemcitabine in refractory stage IV non small-cell lung cancer: a phase II trial. Clinical Lung Cancer. 2: 133-8. PMID 14731324  0.01
2000 Serody JS, Berrey MM, Albritton K, O'Brien SM, Capel EP, Bigelow SH, Weber DJ, Gabriel, Wiley JM, Schell MJ, Gilligan PH, Shea TC. Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantation. Bone Marrow Transplantation. 26: 533-8. PMID 11019843 DOI: 10.1038/Sj.Bmt.1702535  0.24
2000 Serody JS, Sparks SD, Lin Y, Capel EJ, Bigelow SH, Kirby SL, Gabriel DA, Wiley JM, Brecher ME, Schell MJ, Folds J, Shea TC. Comparison of granulocyte colony-stimulating factor (G-CSF)--mobilized peripheral blood progenitor cells and G-CSF--stimulated bone marrow as a source of stem cells in HLA-matched sibling transplantation. Biology of Blood and Marrow Transplantation : Journal of the American Society For Blood and Marrow Transplantation. 6: 434-40. PMID 10975512 DOI: 10.1016/S1083-8791(00)70035-8  0.24
2000 Duell EJ, Millikan RC, Savitz DA, Newman B, Smith JC, Schell MJ, Sandler DP. A population-based case-control study of farming and breast cancer in North Carolina. Epidemiology (Cambridge, Mass.). 11: 523-31. PMID 10955404 DOI: 10.1097/00001648-200009000-00007  0.24
2000 Socinski MA, Rosenman JG, Schell MJ, Halle J, Russo S, Rivera MP, Clark J, Limentani S, Fraser R, Mitchell W, Detterbeck FC. Induction carboplatin/paclitaxel followed by concurrent carboplatin/paclitaxel and dose-escalating conformal thoracic radiation therapy in unresectable stage IIIA/B nonsmall cell lung carcinoma: a modified Phase I trial. Cancer. 89: 534-42. PMID 10931452 DOI: 10.1002/1097-0142(20000801)89:3<534::AID-CNCR8>3.0.CO;2-#  0.24
2000 Brylawski BP, Cohen SM, Cordeiro-Stone M, Schell MJ, Kaufman DG. On the relationship of matrix association and DNA replication. Critical Reviews in Eukaryotic Gene Expression. 10: 91-9. PMID 10813397  0.24
2000 Braeuning MP, Earp JL, O'Brien SM, Schell MJ, Denham AC, Pisano ED, O'Malley MS. Informing patients of diagnostic mammography results: mammographer's opinions. Academic Radiology. 7: 335-40. PMID 10803613 DOI: 10.1016/S1076-6332(00)80007-0  0.24
2000 Huang WY, Newman B, Millikan RC, Schell MJ, Hulka BS, Moorman PG. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. American Journal of Epidemiology. 151: 703-14. PMID 10752798 DOI: 10.1093/Oxfordjournals.Aje.A010265  0.24
2000 Osann KE, Lowery JT, Schell MJ. Small cell lung cancer in women: risk associated with smoking, prior respiratory disease, and occupation. Lung Cancer (Amsterdam, Netherlands). 28: 1-10. PMID 10704703 DOI: 10.1016/S0169-5002(99)00106-3  0.24
2000 Huang WY, Newman B, Millikan RC, Conway K, Hulka BS, Schell MJ, Liu ET. Risk of breast cancer according to the status of HER-2/neu oncogene amplification. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 9: 65-71. PMID 10667465  0.24
2000 Stark A, Hulka BS, Joens S, Novotny D, Thor AD, Wold LE, Schell MJ, Melton LJ, Liu ET, Conway K. HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 18: 267-74. PMID 10637239 DOI: 10.1200/Jco.2000.18.2.267  0.24
2000 Brylawski BP, Cohen SM, Cordeiro-Stone M, Schell MJ, Kaufman DG. On the Relationship of Matrix Association and DNA Replication Critical Reviews™ in Eukaryotic Gene Expression. 10: 9. DOI: 10.1615/Critreveukargeneexpr.V10.I1.100  0.01
2000 Socinski M, Halle J, Schell M, Clark J, Limentani S, Mitchell W, Fraser R, Rosenmann J. Induction (I) and concurrent (C) carboplatin/paclitaxel (C/P) with dose escalated thoracic conformal radiotherapy (TCRT) in stage IIIA/B non-small cell lung cancer (NSCLC): A phase I/II trial Lung Cancer. 29: 99. DOI: 10.1016/S0169-5002(00)80326-8  0.01
2000 Socinski M, Kies M, Unger P, Peterman A, Gillenwater H, Schell M, Bakri K. Second-line (SL) weekly paclitaxel (P) in patients (pts) with advanced non-small cell lung cancer (NSCLC) failing first-line (FL) carboplatin/paclitaxel (C/P) Lung Cancer. 29: 6-7. DOI: 10.1016/S0169-5002(00)80015-X  0.01
2000 Gillenwater HH, Tynan M, Natoli S, Schell MJ, Socinski MA. Second-line gemcitabine in refractory stage IV non-small-cell lung cancer: A phase II trial Clinical Lung Cancer. 2: 133-138.  0.24
1999 Bic Z, Blix GG, Hopp HP, Leslie FM, Schell MJ. The influence of a low-fat diet on incidence and severity of migraine headaches. Journal of Women's Health & Gender-Based Medicine. 8: 623-30. PMID 10839648 DOI: 10.1089/Jwh.1.1999.8.623  0.01
1999 Braeuning MP, Cooper HW, O'Brien S, Burns CB, Washburn DB, Schell MJ, Pisano ED. Effects of processing conditions on mammographic image quality. Academic Radiology. 6: 464-70. PMID 10480042 DOI: 10.1016/S1076-6332(99)80165-2  0.24
1999 Godley PA, Schell MJ. Adjusted odds ratios under nondifferential misclassification: application to prostate cancer. Journal of Clinical Epidemiology. 52: 129-36. PMID 10201653 DOI: 10.1016/S0895-4356(98)00152-8  0.24
1999 Schell MJ. Bridging Different Eras in Sports: Comment Journal of the American Statistical Association. 94: 681. DOI: 10.2307/2669976  0.01
1998 George S, Schell MJ, Detterbeck FC, Socinski MA. Adjuvant Chemotherapy for Resected Non-Small Cell Carcinoma of the Lung: Why We Still Don't Know. The Oncologist. 3: 35-44. PMID 10388082  0.24
1998 Wester RC, Hartway T, Maibach HI, Schell MJ, Northington DJ, Culver BD, Strong PL. In vitro percutaneous absorption of boron as boric acid, borax, and disodium octaborate tetrahydrate in human skin: a summary. Biological Trace Element Research. 66: 111-20. PMID 10050913 DOI: 10.1007/BF02783131  0.24
1998 Wester RC, Hui X, Maibach HI, Bell K, Schell MJ, Northington DJ, Strong P, Culver BD. In vivo percutaneous absorption of boron as boric acid, borax, and disodium octaborate tetrahydrate in humans: a summary. Biological Trace Element Research. 66: 101-9. PMID 10050912 DOI: 10.1007/BF02783130  0.24
1998 Wester RC, Hui X, Hartway T, Maibach HI, Bell K, Schell MJ, Northington DJ, Strong P, Culver BD. In vivo percutaneous absorption of boric acid, borax, and disodium octaborate tetrahydrate in humans compared to in vitro absorption in human skin from infinite and finite doses. Toxicological Sciences : An Official Journal of the Society of Toxicology. 45: 42-51. PMID 9848109 DOI: 10.1006/toxs.1998.2490  0.24
1998 Pisano ED, Earp J, Schell M, Vokaty K, Denham A. Screening behavior of women after a false-positive mammogram Radiology. 208: 245-249. PMID 9646820 DOI: 10.1148/Radiology.208.1.9646820  0.24
1998 Krejn AA, von Borries C, Cage J, Culver A, Tilbury J, de Marinis P, Ashley R, Christiansen H, Lucier A, Cusack P, Hirsch S, Hunt J, Schell M, Butzmann F, Snow M. "Ghosts and Monsters": Contributors' Notes Leonardo Music Journal. 8: 64. DOI: 10.2307/1513403  0.01
1997 Atiba JO, Manzardo AM, Thiruvengadam R, Schell MJ, Meyskens FL. Restoration of oral all-trans retinoic acid bioavailability after a brief drug holiday. American Journal of Therapeutics. 4: 134-40. PMID 10423603 DOI: 10.1097/00045391-199704000-00005  0.01
1997 Bresnitz EA. Epidemiology of advanced lung disease in the United States. Clinics in Chest Medicine. 18: 421-33. PMID 9329867 DOI: 10.1016/s0272-5231(05)70392-0  0.01
1997 Torne A, Puig-Tintore LM, Ordi J, Sanchez E, Manetta A, Schubbert T, Chapman J, Schell MJ, Peng YM, Liao SY, Meyskens F.J. J. Correspondence re: A. Manetta et al., β-Carotene treatment of cervical intraepithelial neoplasia: A Phase II Study. Cancer Epidemiol., Biomarkers and Prev., 5: 929-932, 1996 [1] (multiple letters) Cancer Epidemiology Biomarkers and Prevention. 6: 655-656. PMID 9264282  0.01
1997 Hastings SB, Gallagher J, Bell DA, Watson MA, Schell MJ, Kohlmeier L. Effect of NATI*10 genotype on ex vivo induced calf thymus DNA adducts by human bile Faseb Journal. 11: A441.  0.01
1997 Schell MJ, Singh B. The reduced monotonic regression method Journal of the American Statistical Association. 92: 128-135.  0.24
1996 Manetta A, Schubbert T, Chapman J, Schell MJ, Peng YM, Liao SY, Meyskens FJ. beta-Carotene treatment of cervical intraepithelial neoplasia: a phase II study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 5: 929-32. PMID 8922303  0.01
1995 Wilder-Smith P, Arrastia AM, Schell MJ, Liaw LH, Grill G, Berns MW. Effect of ND:YAG laser irradiation and root planing on the root surface: structural and thermal effects. Journal of Periodontology. 66: 1032-9. PMID 8683415 DOI: 10.1902/Jop.1995.66.12.1032  0.01
1995 Wong DH, Weber EC, Schell MJ, Wong AB, Anderson CT, Barker SJ. Factors associated with postoperative pulmonary complications in patients with severe chronic obstructive pulmonary disease. Anesthesia and Analgesia. 80: 276-84. PMID 7818113 DOI: 10.1097/00000539-199502000-00013  0.01
1995 Dantas ZN, Araujo E, Tadir Y, Berns MW, Schell MJ, Stone SC. Effect of freezing on the relative escape force of sperm as measured by a laser optical trap. Fertility and Sterility. 63: 185-8. PMID 7805910  0.01
1995 Singh B, Schell MJ, Wright FT. Approximations to the powers of the likelihood ratio tests: The loop ordering and slippage alternatives Communications in Statistics - Simulation and Computation. 24: 91-109. DOI: 10.1080/03610919508813232  0.01
1995 Dantas ZN, Araujo E, Tadir Y, Berns MW, Schell MJ, Stone SC. Effect of freezing on the relative escape force of sperm as measured by a laser optical trap*†*Presented at the 8th World Congress of In Vitro Fertilization and Alternate Assisted Reproduction, Kyoto, Japan, September 11 to 15, 1993.†Supported by grant RR-01192 from the National Institutes of Health, Bethesda, Maryland; by grant 000-14-91-C-0134 from the Office of Naval Research, Arlington, Virginia; and by grant DE-FG03-91 ER 61227 from the Department of Energy, Washington, D.C. Fertility and Sterility. 63: 185-188. DOI: 10.1016/S0015-0282(16)57316-6  0.01
1994 Peabody TD, Monson D, Montag A, Schell MJ, Finn H, Simon MA. A comparison of the prognoses for deep and subcutaneous sarcomas of the extremities. The Journal of Bone and Joint Surgery. American Volume. 76: 1167-73. PMID 8056797  0.01
1994 Monk BJ, Chapman JA, Johnson GA, Brightman BK, Wilczynski SP, Schell MJ, Fan H. Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancer. American Journal of Obstetrics and Gynecology. 171: 1193-8. PMID 7977518 DOI: 10.1016/0002-9378(94)90131-7  0.01
1994 Kimel S, Svaasand LO, Hammer-Wilson M, Schell MJ, Milner TE, Nelson JS, Berns MW. Differential vascular response to laser photothermolysis. The Journal of Investigative Dermatology. 103: 693-700. PMID 7963659 DOI: 10.1111/1523-1747.Ep12398548  0.01
1993 Hurwitz CA, Schell MJ, Pui CH, Crist WM, Behm F, Mirro J. Adverse prognostic features in 251 children treated for acute myeloid leukemia. Medical and Pediatric Oncology. 21: 1-7. PMID 8426571 DOI: 10.1002/mpo.2950210102  0.01
1993 Caldwell CW, Patterson WP, Hakami N, Behm FG, Raimondi SC, Schell MJ, Look AT, Rivera GK, Pui CH. CD45 expression and prognosis in acute lymphoblastic leukemia [3] Blood. 81: 562-563. PMID 8422474  0.01
1993 Wile AG, Hourani L, Schell MJ. The contributions of patient factors, physician delay, and tumor biology to the outcome of gastric cancer. The American Surgeon. 59: 850-4. PMID 8256942  0.01
1993 Singh B, Schell MJ, Wright FT. The power functions of the likelihood ratio tests for a simple tree ordering in normal means: Unequal weights Communications in Statistics - Theory and Methods. 22: 425-449. DOI: 10.1080/03610929308831029  0.01
1992 Eguiguren JM, Schell MJ, Crist WM, Kunkel K, Rivera GK. Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood. 79: 871-5. PMID 1737097  0.01
1992 Schell MJ, Ochs JJ, Schriock EA, Carter M. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 10: 128-33. PMID 1727914  0.01
1992 Wiley JS, Snook MB, Jamieson GP, Powell BL, White JC, Gregory BW, Capizzi RL, Belt JA, Schell MJ, Mirro Jnr J. A controversy. Nucleoside transporter expression is correlated with proliferative rate in acute myeloid leukemia Leukemia. 6: 486-488. PMID 1593912  0.01
1992 Pui CH, Carroll AJ, Raimondi SC, Schell MJ, Head DR, Shuster JJ, Crist WM, Borowitz MJ, Link MP, Behm FG. Isochromosomes in childhood acute lymphoblastic leukemia: a collaborative study of 83 cases. Blood. 79: 2384-91. PMID 1571550  0.01
1992 Behm FG, Raimondi SC, Schell MJ, Look AT, Rivera GK, Pui CH. Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features. Blood. 79: 1011-6. PMID 1531305  0.01
1992 Santana VM, Schell MJ, Williams R, Bowman LC, Thompson EI, Brenner MK, Mirro J. Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors. Bone Marrow Transplantation. 10: 457-62. PMID 1464010  0.01
1992 Stute N, Santana VM, Rodman JH, Schell MJ, Ihle JN, Evans WE. Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children. Blood. 79: 2849-54. PMID 1375115  0.01
1992 Hurwitz CA, Krance R, Schell MJ, Santana VM, Brenner MK, Ribeirio R, Roberts WM, Mahmoud H, Belt J, Crom W. Current strategies for treatment of acute myeloid leukemia at St Jude Children's Research Hospital. Leukemia. 6: 39-43. PMID 1374492  0.24
1992 Santana VM, Mirro J, Kearns C, Schell MJ, Crom W, Blakley RL. 2-Chlorodeoxyadenosine produces a high rate of complete hematologic remission in relapsed acute myeloid leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 10: 364-70. PMID 1346800  0.01
1992 Angel CA, Pratt CB, Rao BN, Schell MJ, Parham DM, Lobe TE, Fleming ID. Carcinoembryonic antigen and carbohydrate 19-9 antigen as markers for colorectal carcinoma in children and adolescents. Cancer. 69: 1487-91. PMID 1311626 DOI: 10.1002/1097-0142(19920315)69:6<1487::Aid-Cncr2820690629>3.0.Co;2-0  0.01
1992 Behm F, Raimondi S, Schell M, Look A, Rivera G, Pui C. Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features [see comments] Blood. 79: 1011-1016. DOI: 10.1182/blood.V79.4.1011.bloodjournal7941011  0.01
1992 Behm F, Raimondi S, Schell M, Look A, Rivera G, Pui C. Lack of CD45 antigen on blast cells in childhood acute lymphoblastic leukemia is associated with chromosomal hyperdiploidy and other favorable prognostic features [see comments] Blood. 79: 1011-1016. DOI: 10.1182/blood.v79.4.1011.1011  0.01
1992 Singh B, Schell MJ. On power functions of the likelihood ratio tests for the simple loop order in normal means: Unequal sample sizes Statistics and Probability Letters. 14: 253-267. DOI: 10.1016/0167-7152(92)90055-A  0.01
1991 Koehler M, Schell MJ, Behm FG, Raimondi SC, Woodruff LS, Mirro J. Expression of a novel surface antigen MKW in childhood acute leukemia has prognostic significance. Leukemia. 5: 41-8. PMID 1999957  0.01
1991 Wang WC, Kovnar EH, Tonkin IL, Mulhern RK, Langston JW, Day SW, Schell MJ, Wilimas JA. High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. The Journal of Pediatrics. 118: 377-82. PMID 1999776 DOI: 10.1016/S0022-3476(05)82150-X  0.01
1991 Schriock EA, Schell MJ, Carter M, Hustu O, Ochs JJ. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 9: 400-5. PMID 1999710  0.01
1991 Pui CH, Schell MJ, Vodian MA, Kline S, Mirro J, Crist WM, Behm FG. Serum CD4, CD8, and interleukin-2 receptor levels in childhood acute myeloid leukemia. Leukemia. 5: 249-54. PMID 1901614  0.24
1991 Mahmoud H, Schell M, Pui CH. Cholelithiasis after treatment for childhood cancer Cancer. 67: 1439-1442. PMID 1899356  0.01
1991 Pui CH, Raimondi SC, Head DR, Schell MJ, Rivera GK, Mirro J, Crist WM, Behm FG. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood. 78: 1327-37. PMID 1878594  0.01
1991 Rao BN, Santana VM, Parham D, Pratt CB, Fleming ID, Hudson M, Fontanesi J, Philippe P, Schell MJ. Pediatric nonrhabdomyosarcomas of the extremities. Influence of size, invasiveness, and grade on outcome. Archives of Surgery (Chicago, Ill. : 1960). 126: 1490-5. PMID 1842178 DOI: 10.1001/archsurg.1991.01410360060010  0.01
1991 Pui CH, Schell MJ, Raimondi SC, Head DR, Rivera GK, Crist WM, Behm FG, Borowitz MJ, Shuster JJ, Land VJ, Steuber CP, Pullen DJ, Vietti TJ, Tsuchiya H, Asou N, et al. Myeloid-antigen expression in childhood acute lymphoblastic leukemia [1] New England Journal of Medicine. 325: 1378-1382. PMID 1833646  0.01
1991 Relling MV, Cherrie J, Schell MJ, Petros WP, Meyer WH, Evans WE. Lower prevalence of the debrisoquin oxidative poor metabolizer phenotype in American black versus white subjects. Clinical Pharmacology and Therapeutics. 50: 308-13. PMID 1680593  0.01
1991 Santana VM, Mirro J, Harwood FC, Cherrie J, Schell M, Kalwinsky D, Blakley RL. A phase I clinical trial of 2-chlorodeoxyadenosine in pediatric patients with acute leukemia Journal of Clinical Oncology. 9: 416-422. PMID 1671875  0.01
1990 Evans WE, Schell MJ, Pui CH. MTX clearance is more important for intermediate-risk ALL. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 8: 1115-6. PMID 2348226  0.01
1990 Dahl GV, Kalwinsky DK, Mirro J, Look AT, Pui CH, Murphy SB, Mason C, Ruggiero M, Schell M, Johnson FL, Thomas ED. Allogeneic bone marrow transplantation in a program of intensive sequential chemotherapy for children and young adults with acute nonlymphocytic leukemia in first remission Journal of Clinical Oncology. 8: 295-303. PMID 2299372 DOI: 10.1200/JCO.1990.8.2.295  0.01
1990 Kalwinsky DK, Raimondi SC, Schell MJ, Mirro J, Santana VM, Behm F, Dahl GV, Williams D. Prognostic importance of cytogenetic subgroups in de novo pediatric acute nonlymphocytic leukemia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 8: 75-83. PMID 2295913  0.01
1990 Ribeiro RC, Sandrini Neto RS, Schell MJ, Lacerda L, Sambaio GA, Cat I. Adrenocortical carcinoma in children: a study of 40 cases. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 8: 67-74. PMID 2295912  0.01
1990 Pui CH, Behm FG, Singh B, Rivera GK, Schell MJ, Roberts WM, Crist WM, Mirro J. Myeloid-associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood. 75: 198-202. PMID 2294988  0.01
1990 Pui CH, Behm FG, Singh B, Schell MJ, Williams DL, Rivera GK, Kalwinsky DK, Sandlund JT, Crist WM, Raimondi SC. Heterogeneity of presenting features and their relation to treatment outcome in 120 children with T-cell acute lymphoblastic leukemia. Blood. 75: 174-9. PMID 2136802  0.01
1990 HUTCHINSON RE, SCHELL MJ, NELSON EJ, FISCHL SJ, GARCEZ RB, KUNKEL KD, JACKSON CW, WANG WC, TAYLOR LB, PUI C-. Beneficial Effect of Brief Pre-Transfusion Incubation of Platelets at 37??C Survey of Anesthesiology. 34: 44. DOI: 10.1097/00132586-199002000-00042  0.01
1990 Schell MJ, Kovanar EH, McHaney V, Meyer WH, Kellie SJ. Treatment-related ototoxicity: Reply Journal of Clinical Oncology. 8: 180.  0.01
1989 Carter M, Kalwinsky DK, Dahl GV, Santana VM, Mason CA, Schell MJ. Childhood acute promyelocytic leukemia: a rare variant of nonlymphoid leukemia with distinctive clinical and biologic features. Leukemia. 3: 298-302. PMID 2927178  0.01
1989 Lauer ME, Mulhern RK, Schell MJ, Camitta BM. Long-term follow-up of parental adjustment following a child's death at home or hospital. Cancer. 63: 988-94. PMID 2914304  0.01
1989 Schell MJ, McHaney VA, Green AA, Kun LE, Hayes FA, Horowitz M, Meyer WH. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 7: 754-60. PMID 2715805  0.01
1989 Pinto A, Grant LH, Hayes FA, Schell MJ, Parham DM. Immunohistochemical expression of neuron-specific enolase and Leu 7 in Ewing's sarcoma of bone. Cancer. 64: 1266-73. PMID 2670185  0.01
1989 Hutchinson RE, Kunkel KD, Schell MJ, Jackson CW, Nelson EJ, Wang WC, Fischl SJ, Taylor LB, Garcez RB, Pui CH. Beneficial effect of brief pre-transfusion incubation of platelets at 37 degrees C. Lancet (London, England). 1: 986-8. PMID 2565517  0.01
1989 Schell MJ, Leysieffer FW. An increasing failure rate approach to low-dose extrapolation Biometrics. 45: 1117-1123.  0.01
1988 Pui CH, Kalwinsky DK, Schell MJ, Mason CA, Mirro J, Dahl GV. Acute nonlymphoblastic leukemia in infants: clinical presentation and outcome. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 6: 1008-13. PMID 3373258  0.01
1988 Kalwinsky D, Mirro J, Schell M, Behm F, Mason C, Dahl GV. Early intensification of chemotherapy for childhood acute nonlymphoblastic leukemia: improved remission induction with a five-drug regimen including etoposide Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 6: 1134-1143. PMID 3292713  0.01
1988 Ribeiro RC, Pui CH, Schell MJ. Vertebral compression fracture as a presenting feature of acute lymphoblastic leukemia in children. Cancer. 61: 589-92. PMID 3276382  0.01
1988 Schell MJ, Morrison M. A statistical model of the timing mechanism of the erythrocyte life-span. Blood Cells. 14: 297-311. PMID 3179458  0.01
1987 Meyer WH, Schell MJ, Kumar AP, Rao BN, Green AA, Champion J, Pratt CB. Thoracotomy for pulmonary metastatic osteosarcoma. An analysis of prognostic indicators of survival. Cancer. 59: 374-9. PMID 3542182  0.01
1987 Hughes WT, Rivera GK, Schell MJ, Thornton D, Lott L. Successful intermittent chemoprophylaxis for Pneumocystis carinii pneumonitis. The New England Journal of Medicine. 316: 1627-32. PMID 3495732 DOI: 10.1056/NEJM198706253162604  0.01
1987 Schriock EA, Schell MJ, Ochs JJ. LONGITUDINAL STUDY OF GROWTH IN CHILDREN TREATED FOR ACUTE LYMPHOBLASTIC LEUKEMIA Pediatric Research. 21: 306A-306A. DOI: 10.1203/00006450-198704010-00832  0.01
Hide low-probability matches.